title: Prion infection-impaired functional blocks identified by proteomics enlighten the targets and the curing pathways of an anti-prion drug.
abstract: Prion-induced neurodegeneration results from multiple cellular alterations among which the accumulation of a modified form of the host protein PrP is but a hallmark. Drug treatments need understanding of underlying mechanisms. Proteomics allows getting a comprehensive view of perturbations leading to neuronal death. Heparan sulfate mimetics has proved to be efficient to clear scrapie protein in cultured cells and in animals. To investigate the mechanisms of drug attack, protein profiles of the neuronal cell line GT1 and its chronically Chandler strain infected counterpart were compared, either in steady state cultures or after a 4-day drug treatment. Differentially expressed proteins were associated into functional blocks relevant to neurodegenerative diseases. Protein structure repair and modification, proteolysis, cell shape and energy/oxidation players were affected by infection, in agreement with prion biology. Unexpectedly, novel affected blocks related to translation, nucleus structure and DNA replication were unravelled displaying commonalities with proliferative processes. The drug had a double action in infected cells by reversing protein levels back to normal in some blocks and by heightening survival functions in others. This study emphasizes the interest of a proteomic approach to unravel novel networks involved in prion infection and curing.
authors.affiliation: Biologie Physico-Chimique des Prions, Virologie et Immunologie Moléculaires, INRA, 78352 Jouy-en-Josas Cedex, France. chich@jouy.inra.fr
authors.forename: J-F
authors.initials: JF
authors.lastname: Chich
authors.forename: B
authors.initials: B
authors.lastname: Schaeffer
authors.forename: A-P
authors.initials: AP
authors.lastname: Bouin
authors.forename: F
authors.initials: F
authors.lastname: Mouthon
authors.forename: V
authors.initials: V
authors.lastname: Labas
authors.forename: C
authors.initials: C
authors.lastname: Larramendy
authors.forename: J-P
authors.initials: JP
authors.lastname: Deslys
authors.forename: J
authors.initials: J
authors.lastname: Grosclaude
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents; D002460:Cell Line; D020869:Gene Expression Profiling; D006497:Heparan Sulfate / Q000627:therapeutic use; D051379:Mice; D009419:Nerve Tissue Proteins / Q000032:analysis; D009474:Neurons; D018620:PrPSc Proteins / Q000037:antagonists & inhibitors*; D017096:Prion Diseases / Q000188:drug therapy / Q000503:physiopathology*; D040901:Proteomics; D012608:Scrapie / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D000890:Anti-Infective Agents; D006497:Heparan Sulfate; D009419:Nerve Tissue Proteins; D018620:PrPSc Proteins